低分子肝素治疗急性脑梗死临床疗效观察
摘要
将我院2005年9月～2007年3月收治的52例急性脑梗死患者应用低分子肝素治疗,疗效观察报道如下。
出处
《现代医药卫生》
2007年第16期2447-2447,共1页
Journal of Modern Medicine & Health
参考文献3
-
1张天民,崔慧斐,王凤山,罗振,李华,王福清,杨立波,李素霞,沈渤江.高抗血栓活性的低分子肝素[J].中国医药工业杂志,1994,25(7):301-309. 被引量：38
-
2Kay,Wong KS,RuR,et al.Low molecular weight for the treatment of acute ischemie stroke[J].Eng J Med,1995,333:1588.
-
3叶妮,张临洪.低分子量肝素的药理作用及其在缺血性卒中的临床应用[J].国外医学（脑血管疾病分册）,2001,9(1):45-48. 被引量：70
二级参考文献18
-
1Fareed J, Hoppensteadt DA. Pharmacology of the low-molecular-weight heparins. Semin Thromb Hemost, 1996,22(suppl 2): 13-18.
-
2Jonas S, Sugimori M, Llinas R. Is low molecular weight heparin a neuroprotectant? Ann N Y Acad Sci, 1997, 825:389-393.
-
3Li PA, He QP, Siddiqui MM, et al. Posttreatment with low molecular weight heparin reduces brain edema and infarct volume in rats subjected to thrombotic middle cerebral artery occlusion. Brain Res, 1998, 801(1-2): 220-223.
-
4Baram D, Rashkovsky M, Hershkoviz R, et al. Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell-dependent cutaneous inflammation. Clin Exp Immunol, 1997,110 (3): 485-491.
-
5Schwartz D, Engelhard D, Gallily R, et al. Glial cells production of inflammatory mediators induced by Streptococcus pneumoniae: inhibition by pentoxifylline, low-molecular-weight heparin and dexamethasone. J Neurol Sci, 1998, 155(1): 13-22.
-
6Kay R, Wong KS, Yu YL, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med, 1995, 333(24):1588-1593.
-
7Bijsterveld NR, Hettiarachchi R, Peters R, et al. Low-molecularweight heparins in venous and arterial thrombotic disease. Thromb Haemost, 1999, 82(suppl 1): 139-147.
-
8Bath PM, Iddenden R, Bath FJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke, 2000,31 (7): 1770-1778.
-
9Harenberg J, Weuster B, Pfitzer M, et al. Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin.Semin Thromb Hemost, 1993,19(suppl 1): 116-121.
-
10Berge E, Abdelnoor M, Makstad PH, et al. Low molecular weight heparin versus aspirin in patients with acute ischemic stroke and atrial fibrillation:a double-blind randomized study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet, 2000, 355 (9211) : 1205-1210.
共引文献106
-
1叶勇.疏血通联合低分子肝素治疗进展性脑梗死临床观察[J].实用医技杂志,2008,15(14):1864-1866.
-
2李卫江.低分子肝素治疗急性脑梗死的疗效观察[J].河南实用神经疾病杂志,2004,7(3):74-74.
-
3孙晓萍,刘莉,李金燕.小剂量尿激酶与低分子肝素治疗急性脑梗死的疗效观察[J].实用神经疾病杂志,2004,7(5):29-30. 被引量：1
-
4胡琦,何干平.低分子肝素治疗急性脑梗死82例[J].医药导报,2004,23(9):656-657.
-
5何兆英,岳有详.国产尿激酶联合低分子肝素治疗急性脑梗死[J].潍坊医学院学报,2004,26(3):200-201.
-
6侯冬枝,谢长生,黄寿吾.用注射法和复乳法制备低分子肝素脂质纳米粒[J].中国医院药学杂志,2004,24(11):672-674. 被引量：6
-
7赵建华,林俊杰,马讯,赵文玲.肺心病血栓前状态的抗凝干预[J].中国误诊学杂志,2004,4(6):902-903. 被引量：4
-
8闫鹏,姜玲,姚辉.低分子肝素钙及川芎嗪治疗短暂性脑缺血30例观察[J].中西医结合心脑血管病杂志,2005,3(1):94-94. 被引量：1
-
9赵建华,冯孟森,王倩,赵文玲.抗凝治疗肺心病血栓前状态的临床研究[J].中国医师杂志,2004,6(12):1622-1623. 被引量：16
-
10丘晓琳,李国明,叶俊生.低分子肝素/壳聚糖/海藻酸钠复合微囊的制备及释药性能[J].应用化学,2005,22(4):361-366. 被引量：17
-
1谢祖宏.低分子肝素治疗不稳定型心绞痛57例临床观察[J].中国厂矿医学,1999,12(2):112-112.
-
2王希武,胡明灿,施兆文.低分子肝素治疗不稳定型心绞痛疗效观察[J].现代医药卫生,2006,22(7):1013-1014.
-
3阳跃忠,黄文新,徐彤彤,陈建中.低分子肝素治疗不稳定型心绞痛17例临床观察[J].广西医科大学学报,2000,17(1):133-133. 被引量：1
-
4林德洪.低分子肝素治疗不稳定型心绞痛疗效观察[J].海南医学,2002,13(10):38-39. 被引量：1
-
5隋宏,居兴德.低分子肝素治疗进展性脑梗死疗效观察[J].现代中西医结合杂志,2007,16(1):8-9.
-
6郭庆国.硝酸甘油加低分子肝素治疗不稳定型心绞痛[J].泰山卫生,2003,27(4):64-65.
-
7荆军,乔树斌.低分子肝素治疗进展性脑梗死临床观察[J].中华综合医学,2001,2(7):652-652.
-
8李玉强,张国拣,张玉国.低分子肝素治疗不稳定型心绞痛22例[J].中国药业,2000,9(7):51-51.
-
9王玉光,于炳琦.奥扎格雷钠+低分子肝素治疗80例急性脑梗死观察[J].中国社区医师（医学专业）,2007,9(23):36-36.
-
10陈庆中,于德凯.脉络宁加低分子肝素治疗脑梗塞60例[J].中原医刊,2001,28(6):30-30.
